Skip to main content
Erschienen in: Annals of Hematology 7/2004

01.07.2004 | Case Report

A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis

verfasst von: Hadewijch De Samblanx, Gregor Verhoef, Pierre Zachée, Peter Vandenberghe

Erschienen in: Annals of Hematology | Ausgabe 7/2004

Einloggen, um Zugang zu erhalten

Abstract

In this article we present the case report of a 67-year-old male with a nephrotic syndrome due to a proliferative glomerulonephritis, associated with an angioimmunoblastic T-cell lymphoma. Diagnosis was made on an axillary lymph node biopsy and showed expanded T-cell areas with multiple blood vessels, small mature lymphocytes, eosinophils, and plasma cells. A kidney biopsy was suggestive for a proliferative glomerulonephritis with intra- and extracapillary proliferation. Hypercellular glomeruli were seen, as well as multiple floride crescents. Interstitial edema and fibrosis were absent. Immunohistochemical reactions were negative; there was some mesangial reaction with IgM in the glomeruli. Treatment with high-dose corticosteroids was initiated, with clinical improvement, and was immediately followed by therapy with cyclophosphamide, hydroxydaunomycin, vincristine, and prednisone (CHOP), which induced complete remission with a follow-up of 1 year. To our knowledge, the association of angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis has only been described twice. It concerned elderly men who developed acute renal failure a couple of months after the diagnosis of an angioimmunoblastic T-cell lymphoma. In both, immunoglobulin-containing dense deposits within glomeruli were observed, which was not the case in our patient, where only some mesangial colorization of the IgM in the glomeruli was seen.
Literatur
1.
Zurück zum Zitat Frizzera G, Moran EM, Rappaport H (1974) Angio-immunoblastic lymphadenopathy with dysproteinemia. Lancet I:1070–1073CrossRef Frizzera G, Moran EM, Rappaport H (1974) Angio-immunoblastic lymphadenopathy with dysproteinemia. Lancet I:1070–1073CrossRef
2.
Zurück zum Zitat Ferry JA (2002) Angioimmunoblastic T-cell lymphoma. advances in anatomic pathology 9:273–279CrossRefPubMed Ferry JA (2002) Angioimmunoblastic T-cell lymphoma. advances in anatomic pathology 9:273–279CrossRefPubMed
3.
Zurück zum Zitat Sallah S, Gagnon GA (1998) Review. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment. Acta Haemaol 99:57–64CrossRef Sallah S, Gagnon GA (1998) Review. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment. Acta Haemaol 99:57–64CrossRef
4.
Zurück zum Zitat Stensvold K, Brandtsaeg P, Kvaloy S, Scip M, Lie SO (1984) Imunoblastic lymphadenopathy with early onset in two boys: Immunohistochemical study and indication of decreased proportion of circulating T-helper cells. Br J Hematol 56:417–430 Stensvold K, Brandtsaeg P, Kvaloy S, Scip M, Lie SO (1984) Imunoblastic lymphadenopathy with early onset in two boys: Immunohistochemical study and indication of decreased proportion of circulating T-helper cells. Br J Hematol 56:417–430
5.
Zurück zum Zitat Duwaji MS, Shemin DG, Medeiros LJ, Esparza AR (1995) Proliferative glomerulonephritis with unusual, organized, cylindrical deposits associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma. Arch Pathol Lab Med 119:377–380PubMed Duwaji MS, Shemin DG, Medeiros LJ, Esparza AR (1995) Proliferative glomerulonephritis with unusual, organized, cylindrical deposits associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma. Arch Pathol Lab Med 119:377–380PubMed
6.
Zurück zum Zitat Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMed Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMed
7.
Zurück zum Zitat Brown HA, Macon WR, Kurtin PJ, Gibson LE (2001) Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression. J Cutan Pathol 28:432–438CrossRefPubMed Brown HA, Macon WR, Kurtin PJ, Gibson LE (2001) Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression. J Cutan Pathol 28:432–438CrossRefPubMed
8.
Zurück zum Zitat Knecht H (1989) Angioimmunoblastic lymphadenopathy: ten years’ experience and state of current knowledge. Semin Hematol 26:208–215PubMed Knecht H (1989) Angioimmunoblastic lymphadenopathy: ten years’ experience and state of current knowledge. Semin Hematol 26:208–215PubMed
9.
Zurück zum Zitat Lukes RJ, Tindle BH (1975) Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292:1–8PubMed Lukes RJ, Tindle BH (1975) Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292:1–8PubMed
11.
Zurück zum Zitat Tobinia K, Minato K, Ohtsu T, Muhai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M (1988) Clinicopathologic, immunophenotypic, and immunogenotypic analysis of immunoblastic lymphadenopathy like T-cell lymphoma. Blood 72:1000–1006PubMed Tobinia K, Minato K, Ohtsu T, Muhai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M (1988) Clinicopathologic, immunophenotypic, and immunogenotypic analysis of immunoblastic lymphadenopathy like T-cell lymphoma. Blood 72:1000–1006PubMed
12.
Zurück zum Zitat Yao JL, Cangiarella JF, Cohen JM, Chhieng DC (2001) Fine needle aspiration biopsy of peripheral T-cell lymphomas. A cytologic and immunophenotypic study of 33 cases. Cancer 93:151–159PubMed Yao JL, Cangiarella JF, Cohen JM, Chhieng DC (2001) Fine needle aspiration biopsy of peripheral T-cell lymphomas. A cytologic and immunophenotypic study of 33 cases. Cancer 93:151–159PubMed
13.
Zurück zum Zitat Schlegelberger B, Zwingers T, Hohenadel K, Henne-Bruns D, Schmitz N, et al. (1996) Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. J Clin Oncol 14:593–599PubMed Schlegelberger B, Zwingers T, Hohenadel K, Henne-Bruns D, Schmitz N, et al. (1996) Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. J Clin Oncol 14:593–599PubMed
14.
Zurück zum Zitat Sallah AS, Bernard S (1996) Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine. Ann Hematol 37:295–296CrossRef Sallah AS, Bernard S (1996) Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine. Ann Hematol 37:295–296CrossRef
15.
Zurück zum Zitat Okamura H, Misawa T (1998) Succesfull treatment of AILD by local irradiation. ORL J Otorhinolaryngol Relat Spec 60:233–235CrossRefPubMed Okamura H, Misawa T (1998) Succesfull treatment of AILD by local irradiation. ORL J Otorhinolaryngol Relat Spec 60:233–235CrossRefPubMed
16.
Zurück zum Zitat Sallah S, Wehbir R, Lepera P, et al. (1999) The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia. Br J Haematol 104:163–165CrossRefPubMed Sallah S, Wehbir R, Lepera P, et al. (1999) The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia. Br J Haematol 104:163–165CrossRefPubMed
17.
Zurück zum Zitat Pautier P, Devidas A, Delmer A (1999) Angioimmunoblastic-like T-cell non Hodgkin’s lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 32:545–552PubMed Pautier P, Devidas A, Delmer A (1999) Angioimmunoblastic-like T-cell non Hodgkin’s lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 32:545–552PubMed
18.
Zurück zum Zitat Da’as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, Goldfarb AW, Ben-Yehuda D (2001) Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 67:158–164PubMed Da’as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, Goldfarb AW, Ben-Yehuda D (2001) Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 67:158–164PubMed
19.
Zurück zum Zitat Tipping PG, Holdsworth SR (2003) T cells in glomerulonephritis. Springer Semin Immunopathol 24:377–393PubMed Tipping PG, Holdsworth SR (2003) T cells in glomerulonephritis. Springer Semin Immunopathol 24:377–393PubMed
20.
Zurück zum Zitat Wood WG, Harkins MM Nephropathy in angio-immunoblastic lymphadenopathy. Am J Clin Pathol 71:58–63 Wood WG, Harkins MM Nephropathy in angio-immunoblastic lymphadenopathy. Am J Clin Pathol 71:58–63
Metadaten
Titel
A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis
verfasst von
Hadewijch De Samblanx
Gregor Verhoef
Pierre Zachée
Peter Vandenberghe
Publikationsdatum
01.07.2004
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 7/2004
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-003-0828-5

Weitere Artikel der Ausgabe 7/2004

Annals of Hematology 7/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.